CG Oncology, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2023 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
CG Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2023 to 2024.
  • CG Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $4.99M, a 541% increase year-over-year.
  • CG Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $11.4M, a 646% increase year-over-year.
  • CG Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $11.4M, a 646% increase from 2023.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $11.4M +$9.87M +646% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 $1.53M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.